HomeCompareALIZY vs MRK

ALIZY vs MRK: Dividend Comparison 2026

ALIZY yields 3.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALIZY wins by $1.08M in total portfolio value
10 years
ALIZY
ALIZY
● Live price
3.99%
Share price
$42.78
Annual div
$1.71
5Y div CAGR
57.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.13M
Annual income
$747,958.34
Full ALIZY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ALIZY vs MRK

📍 ALIZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALIZYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALIZY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALIZY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALIZY
Annual income on $10K today (after 15% tax)
$339.13/yr
After 10yr DRIP, annual income (after tax)
$635,764.59/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ALIZY beats the other by $627,436.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALIZY + MRK for your $10,000?

ALIZY: 50%MRK: 50%
100% MRK50/50100% ALIZY
Portfolio after 10yr
$595.0K
Annual income
$378,878.24/yr
Blended yield
63.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ALIZY
Analyst Ratings
3
Buy
Consensus: Buy
Altman Z
-0.7
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALIZY buys
7
MRK buys
0
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$ALIZY▲ Buy$1,001 - $15,0002025-11-19
Gilbert Cisneros🏢 House$ALIZY▲ Buy$1,001 - $15,0002025-10-21
Josh Gottheimer🏢 House$ALIZY▼ Sell$1,001 - $15,0002025-04-09
Josh Gottheimer🏢 House$ALIZY▼ Sell$1,001 - $15,0002024-07-09
Josh Gottheimer🏢 House$ALIZY▼ Sell$1,001 - $15,0002024-06-21
Daniel Goldman🏢 House$ALIZY▼ Sell$50,001 - $100,0002023-07-10
Daniel Goldman🏢 House$ALIZY▲ Buy$1,001 - $15,0002023-03-31
Josh Gottheimer🏢 House$ALIZY▼ Sell$1,001 - $15,0002023-01-11
Josh Gottheimer🏢 House$ALIZY▲ Buy$1,001 - $15,0002022-10-17
Josh Gottheimer🏢 House$ALIZY▼ Sell$1,001 - $15,0002022-09-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALIZYMRK
Forward yield3.99%2.76%
Annual dividend / share$1.71$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.8%32.7%
Portfolio after 10y$1.13M$56.8K
Annual income after 10y$747,958.34$9,798.13
Total dividends collected$1.07M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ALIZY vs MRK ($10,000, DRIP)

YearALIZY PortfolioALIZY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,330$629.58$11,206$366.19+$124.00ALIZY
2$13,175$1,051.93$12,650$502.35+$525.00ALIZY
3$15,901$1,803.98$14,407$694.19+$1.5KALIZY
4$20,225$3,210.97$16,585$967.82+$3.6KALIZY
5$27,664$6,023.18$19,342$1,363.89+$8.3KALIZY
6$41,750$12,149.98$22,913$1,947.19+$18.8KALIZY
7$71,715$27,042.46$27,662$2,823.89+$44.1KALIZY
8$145,240$68,504.96$34,159$4,173.35+$111.1KALIZY
9$360,014$204,607.31$43,337$6,308.80+$316.7KALIZY
10$1,133,174$747,958.34$56,776$9,798.13+$1.08MALIZY

ALIZY vs MRK: Complete Analysis 2026

ALIZYStock

Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide. The company's Property-Casualty segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel to private and corporate customers. Its Life/Health segment provides a range of life and health insurance products on an individual and a group basis, such as annuities, endowment and term insurance, and unit-linked and investment-oriented products, as well as private and supplemental health, and long-term care insurance products. The company's Asset Management segment offers institutional and retail asset management products and services to third-party investors comprising equity and fixed income funds, and multi-assets; and alternative investment products comprising infrastructure debt/equity, real assets, liquid alternatives, and solutions. Its Corporate and Other segment provides banking services for retail clients, as well as digital investment services. Allianz SE was founded in 1890 and is headquartered in Munich, Germany.

Full ALIZY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ALIZY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALIZY vs SCHDALIZY vs JEPIALIZY vs OALIZY vs KOALIZY vs MAINALIZY vs JNJALIZY vs ABBVALIZY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.